IN RE: MIMEDX GROUP, INC. SHAREHOLDER DERIVATIVE LITIGATION

  1. October 09, 2020

    MiMedx Investors Get Initial OK For Fraud Deal, $3.5M In Fees

    A Georgia federal judge has given preliminary approval to a derivative settlement that would require new controls at MiMedx Group Inc. and pay $3.5 million to plaintiffs' counsel to resolve shareholders' allegations that the biotech company's executives engaged in a yearslong scheme to inflate revenue. 

  2. December 07, 2018

    2 Firms Nab Lead In 'Channel-Stuffing' Derivative Suits

    Robbins Arroyo LLP and Kessler Topaz Meltzer & Check LLP have been appointed co-lead counsel in Georgia federal court for three consolidated derivative suits accusing executives of a biotechnology company of submitting bogus purchase orders to the Veterans' Administration to artificially increase its revenue in a "channel-stuffing" scheme.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!